Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Dicerna Pharma
4107
Dicerna Pharma
Health Care
Technology
Biotechnology
Dicerna Pharmaceuticals is focused on the discovery and development ofinnovative treatments for rare inherited diseases.
Suggest edits
Type
B2c
Founded
2007
Raised
$258M
Follow us
Companies in the same industry
Restoration Robotics
Betalin Therapeutics Inc
Abeona Therapeutics
Essia Health
Desktop Genetics
Pneumagen
Symic Biomedical
Recombine
Eleven Biotherapeutics
Proteus Digital Health
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
30 Mar
2017
$70,000,000
Post-IPO equity
RA Capital Management
,
Skyline Ventures
,
Domain Associates
,
+3
Dicerna scores $70 mln
PE HUB
31 Jul
2013
$60,000,000
Venture capital (Series C)
RA Capital Management
,
SR One
,
Skyline Ventures
,
+6
21 Oct
2010
$4,000,000
Venture capital (Series B)
SR One
,
HealthCare Ventures
04 Jan
2010
$124,000,000
Venture capital
Kyowa Hakko Kirin
